Perbandingan Metode Menggunakan Sampel Pasien Rev-1
Perbandingan Metode Menggunakan Sampel Pasien Rev-1
C3 Complement C3 +/- 3 SD
C3 C3 Complement BNII 3 SD
C3 C3 complement S- 8.4%
C4 Complement C4 +/- 3 SD
C4 C4 Complement BNII 3 SD
C4 C4 complement S- 16%
CA125 CA 125 2 SD
CA125 CA125 +/- 3 SD
CA125 CA 125 antigen S- 38.2%
CA125 CA-125 9 U/mL or 30%
CA125 CA125 20 kU/L, 20%
CA15 CA 15-3 2 SD
CA15 CA15-3 +/- 3 SD
CA15 CA 15.3 antigen S- 15.5%
CA15 CA15-3 3 kU/L, 15%
CA19 CA 19-9 2 SD
CA19 CA19-9 +/- 3 SD
CA19 CA 19.9 antigen S- 44.3%
CA19 CA19-9 3 kU/L, 15%
CARBOXY Carboxyhemoglobin 3 SD
CARBOXY Carboxyhemoglobin Radiometer 3 SD
725
CARBOXY Fractional 0.02
Carboxyhemoglobin
CD19 CD19+ 3 SD
CD2 CD2+ 3 SD
CD20 CD20+ 3 SD
CD3 CD3+ 3 SD
CD3 CD3+/CD4+ 3 SD
CD3 CD3+/CD8+ 3 SD
CD3 CD3-/CD16+56+ 3 SD
CD4 CD4+ 3 SD
CD5 CD5+ 3 SD
CD8 CD8+ 3 SD
CI Chloride +/- 5%
CI Chloride -urine U- 5%
CI Chloride AU640 5%
CI Chloride Radiometer 5%
725
CI Chloride, urine U- AU640 3 SD
CI Chloride S- 1.5%
CI Chloride 3.0 mmol/L
CI Chloride-Sweat Sweat 2 mmol/L, 10%
CI Chloride-Urine U- 2.0 mmol/L, 10%
CI Chloride 5%
FT3 Free T3 3 SD
FT3 Triiodothyronine, Free 1.5 pg/mL or 30%
(Free T3)
FT3 Free T3 3.0 pmol/L
FT3 Triiodothyronine - Free 20%
HGB Hemoglobin,total 7%
HGB Hemoglobin, Urine 80% Agreement
(qual)
HGB Hemoglobin B- 4.1%
HGB Hemoglobin 3 g/L, 3%
concentration
IGK Immunoglobulins K S- 8%
chain
INR INR 2 SD
LH LH 2.5 SD
LH LH +/-25% or 1.5 IU/L
LH LH Centaur 3 SD
LH Luteinizing hormone S- 19.8%
LH Luteinizing Hormone 2 mIU/mL or 25%
LH LH 2.0 IU/L, 20%
LH Luteinizing Hormone 2 SD
MCV MCV 3 SD
MCV Mean corpuscular (B)Erythr- 2.3%
volume (MCV)
METHGB Methemoglobin 3 SD
METHGB Methemoglobin Radiometer 2%
725
METHGB Fractional 1.0, 10%
Methemoglobin
METHOT Methotrexate 0.1 umol/L, 10%
METHOT Methotrexate 25%
MYOGLOB Myoglobin - 2 SD
quantitative
MYOGLOB Myoglobin S- 19.6%
MYOGLOB Myoglobin 15 ng/mL or 30%
MYOGLOB Myoglobin 30%
OSMOL Osmolality,serum 3 SD
OSMOL Osmolality,urine U- 3 SD
OSMOL Osmolality Freezing point 2 SD
OXYHGB Oxyhemoglobin 3 SD
OXYHGB Oxyhemoglobin Radiometer
725
OXYHGB Fractional 3, 4%
Oxyhemoglobin
PAP PAP 2.5 SD
RETIC Reticulocytes 3 SD
RETIC Reticulocyte highly S- 24%
fluorescent, count
RETIC Reticulocyte low S- 2.6%
fluorescent, count
RETIC Reticulocyte medium S- 19.6%
fluorescent, count
RETIC Reticulocyte, count S- 16.8%
RETIC Reticulocyte Count 0.50% or 30%
T3 Triiodothyronine +/- 3 SD
T3 T3, T3 Centaur 3 SD
T3 Triiodothyronine (T3) S- 11.4%
T3 Triiodothyronine, Total 3SD
(T3)
T3 Total T3 0.3 nmol/L, 20%
(Endocrinology)
T3 Total T3 (General 0.3 nmol/L, 15%
Chemistry)
T3 Triiodothyronine - 20%
Total
TROPONIN Troponin I - 2 SD
quantitative
TROPONIN Troponin T - qualitative Pos/Neg
TROPONIN Troponin T - 2 SD
quantitative
TROPONIN Troponin I Centaur not evaluated
TROPONIN Troponin I 0.9 ng/mL or 30%
TROPONIN Troponin T 0.1 ng/mL or 30%
TROPONIN Troponin I 0.2 ng/mL, 10%
TROPONIN Troponin T 0.1 ng/mL, 10%
TROPONIN Troponin I 2 SD
TROPONIN Troponin T 2 SD
7 RCPA
5 BV
1 CLIA, 3 NYS,
6 AAB
4 CAP
5 BV
6 AAB
5 BV
2 WLSH
3 NYS
4 CAP
6 AAB
8 CFX
2 WLSH
5 BV
5 BV
7 RCPA
7 RCPA
3 NYS
2 WLSH
2 WLSH
6 AAB
7 RCPA
5 BV
7 RCPA
1 CLIA, 2
WLSH
2 WLSH
3 NYS
3 NYS
3 NYS
4 CAP
4 CAP
4 CAP
7 RCPA
7 RCPA
1 CLIA
7 RCPA
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
4 CAP
4 CAP
5 BV
5 BV
5 BV
7 RCPA
7 RCPA
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 6 AAB
2 WLSH
3 NYS
3 NYS
4 CAP
4 CAP
4 CAP
6 AAB
7 RCPA
8 CFX
5 BV
5 BV
7 RCPA
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
5 BV
6 AAB
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
2 WLSH
7 RCPA
8 CFX
7 RCPA
7 RCPA
8 CFX
2 WLSH
4 CAP
5 BV
6 AAB
7 RCPA
2 WLSH
3 NYS
3 NYS
4 CAP
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
4 CAP
4 CAP
5 BV
5 BV
5 BV
7 RCPA
8 CFX
1 CLIA, 3 NYS
5 BV
7 RCPA
2 WLSH
3 NYS
7 RCPA
8 CFX
5 BV
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
4 CAP
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
5 BV
6 AAB
1 CLIA, 3 NYS
4 CAP
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
2 WLSH
3 NYS
4 CAP
5 BV
7 RCPA
2 WLSH
3 NYS
4 CAP
3 NYS
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
2 WLSH
3 NYS
4 CAP
4 CAP
5 BV
5 BV
6 AAB
6 AAB
7 RCPA
7 RCPA
7 RCPA
7 RCPA
8 CFX
8 CFX
8 CFX
2 WLSH
4 CAP
6 AAB
3 NYS
1 CLIA, 3 NYS,
6 AAB
4 CAP
5 BV
1 CLIA, 3 NYS,
6 AAB
4 CAP
5 BV
1 CLIA
4 CAP
5 BV
6 AAB
6 AAB
7 RCPA
8 CFX
2 WLSH
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
2 WLSH
4 CAP
5 BV
5 BV
7 RCPA
2 WLSH
3 NYS
5 BV
6 AAB
7 RCPA
2 WLSH
3 NYS
5 BV
7 RCPA
2 WLSH
3 NYS
5 BV
7 RCPA
3 NYS
5 BV
8 CFX
7 RCPA
1 CLIA, 2
WLSH, 6 AAB
3 NYS
4 CAP
4 CAP
7 RCPA
8 CFX
2 WLSH
4 CAP
7 RCPA
5 BV
6 AAB
7 RCPA
5 BV
5 BV
2 WLSH
2 WLSH
2 WLSH
2 WLSH
2 WLSH
2 WLSH
2 WLSH
2 WLSH
2 WLSH
2 WLSH
2 WLSH
2 WLSH
3 NYS
4 CAP
7 RCPA
1 CLIA, 3 NYS
4 CAP
5 BV
5 BV
5 BV
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
5 BV
5 BV
5 BV
6 AAB
7 RCPA
8 CFX
2 WLSH
3 NYS
4 CAP
5 BV
6 AAB
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
4 CAP
4 CAP
4 CAP
5 BV
7 RCPA
7 RCPA
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
4 CAP
5 BV
5 BV
5 BV
6 AAB
7 RCPA
8 CFX
8 CFX
2 WLSH
4 CAP
6 AAB
7 RCPA
8 CFX
2 WLSH
4 CAP
7 RCPA
5 BV
5 BV
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
7 RCPA
8 CFX
5 BV
5 BV
7 RCPA
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
2 WLSH
4 CAP
4 CAP
5 BV
5 BV
5 BV
5 BV
5 BV
6 AAB
7 RCPA
7 RCPA
8 CFX
2 WLSH
4 CAP
4 CAP
5 BV
6 AAB
6 AAB
3 NYS
4 CAP
5 BV
2 WLSH
2 WLSH
2 WLSH
6 AAB
5 BV
5 BV
8 CFX
2 WLSH
7 RCPA
8 CFX
6 AAB
1 CLIA, 2
WLSH, 6 AAB
3 NYS
4 CAP
7 RCPA
8 CFX
5 BV
7 RCPA
8 CFX
6 AAB
7 RCPA
7 RCPA
7 RCPA
7 RCPA
5 BV
5 BV
3 NYS
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
5 BV
6 AAB
2 WLSH
6 AAB
6 AAB
2 WLSH
3 NYS
5 BV
6 AAB
7 RCPA
8 CFX
2 WLSH
3 NYS
3 NYS
7 RCPA
7 RCPA
8 CFX
8 CFX
2 WLSH
1 CLIA, 2
WLSH
3 NYS
7 RCPA
8 CFX
5 BV
5 BV
5 BV
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
5 BV
3 NYS
2 WLSH
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
4 CAP
2 WLSH
2 WLSH
4 CAP
5 BV
5 BV
6 AAB
7 RCPA
8 CFX
3 NYS
5 BV
7 RCPA
2 WLSH
3 NYS
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
2 WLSH
6 AAB
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 3 NYS
4 CAP
5 BV
6 AAB
7 RCPA
7 RCPA
8 CFX
7 RCPA
1 CLIA, 2
WLSH, 6 AAB
3 NYS
4 CAP
7 RCPA
8 CFX
2 WLSH
3 NYS
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
7 RCPA
5 BV
5 BV
5 BV
5 BV
5 BV
5 BV
6 AAB
7 RCPA
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
2 WLSH
2 WLSH
3 NYS
4 CAP
4 CAP
4 CAP
5 BV
5 BV
6 AAB
7 RCPA
7 RCPA
7 RCPA
7 RCPA
8 CFX
5 BV
5 BV
4 CAP
5 BV
2 WLSH
2 WLSH
2 WLSH
5 BV
6 AAB
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
3 NYS
3 NYS
3 NYS
4 CAP
6 AAB
7 RCPA
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
5 BV
1 CLIA
3 NYS
3 NYS
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
3 NYS
5 BV
7 RCPA
5 BV
7 RCPA
3 NYS
4 CAP
5 BV
6 AAB
8 CFX
7 RCPA
5 BV
5 BV
5 BV
5 BV
7 RCPA
7 RCPA
8 CFX
1 CLIA, 3 NYS,
6 AAB
4 CAP
5 BV
1 CLIA
3 NYS
6 AAB
6 AAB
7 RCPA
7 RCPA
1 CLIA, 3 NYS,
6 AAB
4 CAP
4 CAP
4 CAP
5 BV
7 RCPA
5 BV
5 BV
1 CLIA, 3 NYS,
6 AAB
4 CAP
5 BV
8 CFX
4 CAP
4 CAP
2 WLSH
3 NYS
5 BV
7 RCPA
5 BV
5 BV
5 BV
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
4 CAP
3 NYS
2 WLSH
4 CAP
4 CAP
5 BV
7 RCPA
7 RCPA
7 RCPA
8 CFX
5 BV
6 AAB
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
1 CLIA, 3 NYS
5 BV
5 BV
5 BV
6 AAB
5 BV
5 BV
1 CLIA, 2
WLSH
4 CAP
2 WLSH
3 NYS
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
7 RCPA
2 WLSH
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
5 BV
6 AAB
8 CFX
1 CLIA, 2
WLSH, 6 AAB
3 NYS
4 CAP
7 RCPA
8 CFX
5 BV
5 BV
5 BV
2 WLSH
5 BV
7 RCPA
2 WLSH
3 NYS
4 CAP
2 WLSH
4 CAP
7 RCPA
7 RCPA
8 CFX
2 WLSH
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
4 CAP
4 CAP
5 BV
5 BV
5 BV
5 BV
5 BV
5 BV
7 RCPA
7 RCPA
8 CFX
8 CFX
2 WLSH
4 CAP
6 AAB
5 BV
5 BV
5 BV
5 BV
1 CLIA
5 BV
5 BV
4 CAP
4 CAP
5 BV
2 WLSH
2 WLSH
5 BV
6 AAB
8 CFX
5 BV
5 BV
5 BV
5 BV
7 RCPA
7 RCPA
7 RCPA
8 CFX
7 RCPA
5 BV
4 CAP
2 WLSH
3 NYS
4 CAP
2 WLSH
2 WLSH
4 CAP
4 CAP
5 BV
6 AAB
7 RCPA
7 RCPA
8 CFX
5 BV
5 BV
5 BV
2 WLSH
4 CAP
7 RCPA
2 WLSH
7 RCPA
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
5 BV
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
3 NYS
4 CAP
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
2 WLSH
3 NYS
4 CAP
1 CLIA, 2
WLSH, 6 AAB
3 NYS
4 CAP
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 6 AAB
3 NYS
3 NYS
4 CAP
4 CAP
7 RCPA
8 CFX
5 BV
7 RCPA
5 BV
5 BV
5 BV
5 BV
7 RCPA
2 WLSH
2 WLSH
3 NYS
4 CAP
4 CAP
6 AAB
6 AAB
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
5 BV
6 AAB
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
6 AAB
7 RCPA
8 CFX
6 AAB
7 RCPA
7 RCPA
7 RCPA
7 RCPA
7 RCPA
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
4 CAP
4 CAP
4 CAP
5 BV
5 BV
5 BV
5 BV
7 RCPA
7 RCPA
7 RCPA
8 CFX
2 WLSH
4 CAP
5 BV
6 AAB
1 CLIA, 2
WLSH, 6 AAB
3 NYS
8 CFX
1 CLIA, 2
WLSH, 6 AAB
3 NYS
3 NYS
4 CAP
4 CAP
4 CAP
6 AAB
6 AAB
8 CFX
8 CFX
5 BV
5 BV
2 WLSH
3 NYS
4 CAP
6 AAB
7 RCPA
8 CFX
2 WLSH
3 NYS
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
5 BV
2 WLSH
3 NYS
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
2 WLSH
3 NYS
4 CAP
4 CAP
4 CAP
4 CAP
4 CAP
4 CAP
4 CAP
5 BV
5 BV
5 BV
5 BV
5 BV
5 BV
6 AAB
6 AAB
7 RCPA
7 RCPA
7 RCPA
8 CFX
2 WLSH
2 WLSH
3 NYS
3 NYS
3 NYS
4 CAP
5 BV
6 AAB
7 RCPA
7 RCPA
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
5 BV
6 AAB
6 AAB
6 AAB
4 CAP
7 RCPA
5 BV
5 BV
1 CLIA, 2
WLSH, 6 AAB
3 NYS
4 CAP
7 RCPA
8 CFX
5 BV
7 RCPA
7 RCPA
2 WLSH
5 BV
5 BV
5 BV
5 BV
6 AAB
5 BV
1 CLIA
3 NYS
4 CAP
5 BV
1 CLIA
2 WLSH
3 NYS
4 CAP
6 AAB
7 RCPA
8 CFX
5 BV
5 BV
5 BV
7 RCPA
5 BV
7 RCPA
2 WLSH
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
4 CAP
4 CAP
4 CAP
5 BV
5 BV
5 BV
5 BV
5 BV
7 RCPA
7 RCPA
7 RCPA
8 CFX
3 NYS
6 AAB
6 AAB
6 AAB
6 AAB
5 BV
5 BV
6 AAB
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
6 AAB
7 RCPA
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
6 AAB
7 RCPA
7 RCPA
8 CFX
5 BV
7 RCPA
2 WLSH
2 WLSH
3 NYS
4 CAP
5 BV
5 BV
6 AAB
7 RCPA
8 CFX
2 WLSH
3 NYS
4 CAP
1 CLIA, 2
WLSH, 6 AAB
3 NYS
4 CAP
7 RCPA
8 CFX
5 BV
2 WLSH
4 CAP
4 CAP
6 AAB
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 6 AAB
3 NYS
4 CAP
7 RCPA
8 CFX
5 BV
5 BV
5 BV
2 WLSH
4 CAP
5 BV
5 BV
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
7 RCPA
8 CFX
2 WLSH
2 WLSH
2 WLSH
2 WLSH
4 CAP
6 AAB
6 AAB
7 RCPA
7 RCPA
8 CFX
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
4 CAP
5 BV
6 AAB
7 RCPA
8 CFX
3 NYS
6 AAB
8 CFX
5 BV
5 BV
5 BV
7 RCPA
7 RCPA
1 CLIA
2 WLSH
4 CAP
4 CAP
5 BV
5 BV
5 BV
7 RCPA
7 RCPA
7 RCPA
8 CFX
1 CLIA, 2
WLSH, 3 NYS,
6 AAB
2 WLSH
4 CAP
4 CAP
6 AAB
6 AAB
8 CFX
1 CLIA, 2
WLSH, 6 AAB
3 NYS
4 CAP
4 CAP
6 AAB
7 RCPA
8 CFX
2 WLSH
3 NYS
4 CAP
6 AAB
7 RCPA
8 CFX
5 BV
7 RCPA
2 WLSH
3 NYS
4 CAP
6 AAB
7 RCPA
5 BV
7 RCPA
7 RCPA
5 BV
1 CLIA
5 BV
6 AAB
1 CLIA, 2
WLSH
5 BV
5 BV
3 NYS
Data Total Imprecision :
Level 1 Level 2
Pengulangan Pe
Hari 1 2 3 4 5 Hari 1
1 103.6 101.6 101.7 101.5 101 1 86.5
2 103.6 101.5 101.6 101.3 101.4 2 86.4
3 103.9 101.6 101.7 101.1 101.4 3 86.3
4 102.4 101.7 101.8 101.6 101.5 4 86.8
5 103.8 101.7 101.9 101.9 101.3 5 86.8
RE metoda Y ?
SE Metoda Y ?
TE metoda Y ?
korelasi antara metoda X dengan metoda Y ?
persamaan regresi antara metoda X dengan metoda Y ?
kinerja metoda Y dibandingkan dengan Metoda X ?
posisi level 1 dan 2 pada MDL ?
Entry Data pada sel berwarna Kuning
EP 15 Presisi
Level 1
Jml replikasi 5
Jumlah hari 5
Rep.1 Rep.2 Rep.3 Rep.4
Hari 1
Hari 2
Hari 3
Hari 4
Hari 5
Mean KeseluruAV(E5;E9)
Varian Within rAV(G5;G9)
SD Within run SQRT(E12)
SD Between ruSD(E5;E9)
Varian BetweenE14^2
Total Varian ((B2-1)/B2)*E12+E15
SD Laboratori SQRT(E17)
CV Laboratori (E18/E11)*100
Sigma Limits
EP 15 Presisi
Level
Jml replikasi
Jumlah hari
Rep.5 Run Mean Run SD Varian
Hari 1
Hari 2
Hari 3
Hari 4
Hari 5
Mean Keseluruh
Varian Within ru
SD Within run
SD Between run
Varian Between
Total Varian
SD Laboratorium
CV Laboratorium
15.00
10.00
Pembanding (%)
5.00
0.00
0 2 4 6 8 10 12 14 16 18 20 22
-5.00
-10.00
-15.00
-20.00
Nomor Data
6
4
f(x) = NaN x + NaN
R² = 0 Diagram Tebar Metode Uji dengan Me
12
10
8
Metode Uji
6
4
2
0
0
Metode Pembanding
ANALIS
UJI
METODA UJI (Y)
METODA PEMBANDING (X)
TEa
PERHITUNGAN REGRESI
SLOPE
INTERCEPT
R
R²
PERSAMAAN GARIS Yc = +
Level 1
% Unit yg diukur
Xc Medical Decision Concentration (MDC) 100
Yc MDC Prediksi pers. Regresi
SE Yc-Xc
RE Uji Impresisi (RE)
1.96 x SD atau 1.96 x CV
TE SE + 1.96 RE
Sigma (TEa- |Bias|)/CV
TEa Lihat Tabel TEa 10
Kesimpulan Kinerja tdk diterima
Quality Requirement
TEa 10.0
Offset 0.0
d Inaccuracy, % Bias
12.0
Method Performance Level 1 Level 2
Bias (% diff)
10.0
Imprecision (% CV)
Sigma Limits s
8.0
6 1.67
5 2.00
6.0
4.0
Observed Inaccuracy,
8.0
6.0
4 2.50
3 3.33
4.0
2 5.00
2.0
0.0
0.00
15 Presisi
2
5
5
Rep.1 Rep.2 Rep.3 Rep.4 Rep.5 Run Mean
AVERAGE(N6:N10)
AVERAGE(P6:P10)
SQRT(N13)
STDEV(N6:N10)
N15^2
((K3-1)/K3)*N13+N16
SQRT(N18)
(N19/N12)*100
et pembanding
16 18 20 22 24 26 28 30 32 34 36 38 40 42
Nomor Data
100
Metode Pembanding
Xc
Level 2
% Unit yg diukur
85
10
Kinerja tdk diterima
12.0
10.0
8.0
6.0
4.0
Observed Inaccuracy,
8.0
6.0
4.0
2.0
0.0
0.00 1.00 2.00 3.00 4.00 5.00 6
Observed Imprecision, % CV
Run SD Varian
6 Sigma (World Class)
5 Sigma (Excelent)
4 Sigma (Good)
3 Sigma (Marginal)
2 Sigma (Poor)
Level 1
Level 2
6 Sigma (World Class)
5 Sigma (Excelent)
4 Sigma (Good)
3 Sigma (Marginal)
2 Sigma (Poor)
Level 1
Level 2
5.00 6.00
Entry Data pada sel berwarna Kuning
EP 15 Presisi
Level
Jml replikasi
Jumlah hari
Rep.1 Rep.2 Rep.3 Rep.4
Hari 1
Hari 2
Hari 3
Hari 4
Hari 5
Mean KeseluruAV(E5;E9)
Varian Within rAV(G5;G9)
SD Within run SQRT(E12)
SD Between ruSD(E5;E9)
Varian BetweenE14^2
Total Varian ((B2-1)/B2)*E12+E15
SD Laboratori SQRT(E17)
CV Laboratori (E18/E11)*100
Sigma Limits
EP 15 Presisi
Level
Jml replikasi
Jumlah hari
Rep.5 Run Mean Run SD Varian
Hari 1
Hari 2
Hari 3
Hari 4
Hari 5
Mean Keseluruh
Varian Within ru
SD Within run
SD Between run
Varian Between
Total Varian
SD Laboratorium
CV Laboratorium
15.00
10.00
Pembanding (%)
5.00
0.00
0 2 4 6 8 10 12 14 16 18 20 22
-5.00
-10.00
-15.00
-20.00
Nomor Data
6
4
f(x) = NaN x + NaN
R² = 0 Diagram Tebar Metode Uji dengan Me
12
10
8
Metode Uji
6
4
2
0
0
Metode Pembanding
ANALIS
UJI
METODA UJI (Y)
METODA PEMBANDING (X)
TEa
PERHITUNGAN REGRESI
SLOPE
INTERCEPT
R
R²
PERSAMAAN GARIS Yc = 0.00 +
Level 1
% Unit yg diukur
Xc Medical Decision Concentration (MDC)
Yc MDC Prediksi pers. Regresi
SE Yc-Xc
RE Uji Impresisi (RE) 0.000
1.96 x SD atau 1.96 x CV
TE SE + 1.96 RE
Sigma (TEa- |Bias|)/CV
TEa Lihat Tabel TEa
Kesimpulan
Quality Requirement
TEa
Offset 0.0
d Inaccuracy, % Bias
12.0
Method Performance Level 1 Level 2
Bias (% diff)
10.0
Imprecision (% CV) 0 0
Sigma Limits s
8.0
6
5
6.0
4.0
Observed Inaccuracy,
8.0
6.0
4
3
4.0
2
2.0
0.0
0.00 0.10
15 Presisi
AVERAGE(N6:N10)
AVERAGE(P6:P10)
SQRT(N13)
STDEV(N6:N10)
N15^2
((K3-1)/K3)*N13+N16
SQRT(N18)
(N19/N12)*100
et pembanding
16 18 20 22 24 26 28 30 32 34 36 38 40 42
Nomor Data
100
Metode Pembanding
0.000 Xc
Level 2
% Unit yg diukur
0.000
12.0
10.0
8.0
6.0
4.0
Observed Inaccuracy,
8.0
6.0
4.0
2.0
0.0
0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 0.90 1
Observed Imprecision, % CV
Run SD Varian
6 Sigma (World Class)
5 Sigma (Excelent)
4 Sigma (Good)
3 Sigma (Marginal)
2 Sigma (Poor)
Level 1
Level 2
6 Sigma (World Class)
5 Sigma (Excelent)
4 Sigma (Good)
3 Sigma (Marginal)
2 Sigma (Poor)
Level 1
Level 2